Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm.

Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP.

Psychopharmacology (Berl). 2003 Sep;169(3-4):314-20. Epub 2003 Feb 28.

PMID:
12610717
2.

Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.

Chang T, Meyer U, Feldon J, Yee BK.

Psychopharmacology (Berl). 2007 Apr;191(2):211-21. Epub 2006 Dec 19.

PMID:
17180617
3.

Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.

McDonald LM, Moran PM, Vythelingum GN, Joseph MH, Stephenson JD, Gray JA.

Psychopharmacology (Berl). 2003 Sep;169(3-4):321-31. Epub 2002 Aug 9.

PMID:
14530903
4.

Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI.

Young AM, Kumari V, Mehrotra R, Hemsley DR, Andrew C, Sharma T, Williams SC, Gray JA.

Behav Brain Res. 2005 Jan 30;156(2):277-88.

PMID:
15582114
5.

Enhanced visual latent inhibition in obsessive-compulsive disorder.

Swerdlow NR, Hartston HJ, Hartman PL.

Biol Psychiatry. 1999 Feb 15;45(4):482-8.

PMID:
10071722
6.

Enhancement of latent inhibition in patients with chronic schizophrenia.

Gal G, Barnea Y, Biran L, Mendlovic S, Gedi T, Halavy M, Feldon J, Fennig S, Levkovitz Y.

Behav Brain Res. 2009 Jan 30;197(1):1-8. doi: 10.1016/j.bbr.2008.08.023. Epub 2008 Aug 28.

PMID:
18793680
7.

A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.

Lipina T, Roder J.

Psychopharmacology (Berl). 2010 Feb;208(3):487-98. doi: 10.1007/s00213-009-1749-3. Epub 2009 Dec 16.

PMID:
20013111
8.

Psychopharmacology of latent inhibition: a neural network approach.

Schmajuk NA, Buhusi CV, Gray JA.

Behav Pharmacol. 1998 Dec;9(8):711-30.

PMID:
9890261
9.

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

Weiner I, Shadach E, Tarrasch R, Kidron R, Feldon J.

Biol Psychiatry. 1996 Nov 1;40(9):834-43.

PMID:
8896769
10.

The role of dopamine in conditioning and latent inhibition: what, when, where and how?

Young AM, Moran PM, Joseph MH.

Neurosci Biobehav Rev. 2005;29(6):963-76. Review.

PMID:
16045987
11.
12.

Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans.

Salgado JV, Hetem LA, Vidal M, Graeff FG, Danion JM, Sandner G.

Behav Brain Res. 2000 Dec 20;117(1-2):61-7.

PMID:
11099758
13.

A demonstration of within-subjects latent inhibition in the human: limitations and advantages.

Gray NS, Snowden RJ, Peoples M, Hemsley DR, Gray JA.

Behav Brain Res. 2003 Jan 6;138(1):1-8.

PMID:
12493625
14.

A neurotoxic lesion of serotonergic neurones using 5,7-dihydroxytryptamine does not disrupt latent inhibition in paradigms sensitive to low doses of amphetamine.

De Oliveira Mora P, Fouquet N, Oberling P, Gobaille S, Graeff FG, Sandner G.

Behav Brain Res. 1999 Apr;100(1-2):167-75.

PMID:
10212064
15.

Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.

Melo LL, Pereira EC, Pagini CH, Coimbra NC, Brandão ML, Ferrari EA.

Exp Neurol. 2009 Mar;216(1):16-21. doi: 10.1016/j.expneurol.2008.10.020. Epub 2008 Nov 24.

PMID:
19084523
16.

Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.

Russig H, Kovacevic A, Murphy CA, Feldon J.

Psychopharmacology (Berl). 2003 Nov;170(3):263-70. Epub 2003 Jul 25.

PMID:
12898122
17.

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Baruch I, Hemsley DR, Gray JA.

J Nerv Ment Dis. 1988 Oct;176(10):598-606.

PMID:
2903219
18.

Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition.

Bethus I, Muscat R, Goodall G.

Behav Neurosci. 2006 Jun;120(3):554-62.

PMID:
16768607
19.

Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm.

Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Minassian A, Auerbach PP.

Schizophr Res. 2005 Jan 1;72(2-3):169-83.

PMID:
15560962
20.

Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients.

Gal G, Mendlovic S, Bloch Y, Beitler G, Levkovitz Y, Young AM, Feldon J, Ratzoni G.

Behav Brain Res. 2005 Apr 30;159(2):267-75. Epub 2005 Jan 11.

PMID:
15817189

Supplemental Content

Support Center